List view / Grid view
6 August 2015 | By Victoria White
NICE has opened a second consultation on preliminary draft guidance on olaparib for maintenance treatment of ovarian, fallopian tube and peritoneal cancer...
5 August 2015 | By Victoria White
Pivotal trial results from Phase III studies of Vanda Pharmaceuticals’ Hetlioz® (tasimelteon) have been published in The Lancet...
5 August 2015 | By Victoria White
Lilly has notified UCSD of its intent to end its contract with the University for the management of the Alzheimer's disease A4 study...
5 August 2015 | By Victoria White
The Intellectual Property and Science business of Thomson Reuters has released its 2015 CMR Factbook, pharma's leading resource of global R&D trends...
5 August 2015 | By Victoria White
The ECs has approved Pfizer’s pending acquisition of Hospira - a transaction that will greatly expand Pfizer's sterile injectable pharmaceuticals portfolio...
4 August 2015 | By Victoria White
The EC has granted orphan drug designation to Solgenix’s synthetic hypericin (the active ingredient in SGX301) for the treatment of cutaneous T-cell lymphoma...
4 August 2015 | By Victoria White
Shire made a proposal to Baxalta on 10 July 2015 to combine the companies in an all-stock transaction worth approximately $30.6 billion...
4 August 2015 | By Victoria White
Toujeo is now available in the UK, providing another option for adults with type 1 and type 2 diabetes mellitus to help manage their condition...
4 August 2015 | By Victoria White
The FDA has approved 3D printed drug Spritam for the treatment of of partial onset seizures, myoclonic seizures and generalised tonic-clonic seizures...
4 August 2015 | By Victoria White
Pfizer and Synthon have entered into an agreement whereby Pfizer has acquired the exclusive commercialisation rights in the US to glatiramer acetate...
3 August 2015 | By Victoria White
The FDA has accepted Mundipharma EDO’s IND for EDO-S101, a fusion molecule to treat relapsed/refractory haematologic malignancies and solid tumours...
3 August 2015 | By Victoria White
Shire has acquired Foresight Biotherapeutics, gaining global rights to FST-100 - a therapy in development for the treatment of infectious conjunctivitis...
3 August 2015 | By Victoria White
Celyad has completed the injection procedure for the last patient enrolled in CHART-1, its Phase III clinical trial of cardiovascular candidate, C-Cure...
3 August 2015 | By Victoria White
Cell Therapy Catapult has awarded a contract to CTL to accelerate its clinical programme to develop an engineered T cell treatment for blood cancers...
3 August 2015 | By Victoria White
A combination of three proteins found at high levels in urine can accurately detect early-stage pancreatic cancer, researchers have found...
